ENDRA Life Sciences Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. NOTABLESCHEDULE 13DENDRA Life Sciences Inc.NDRAOct 8

   ASPI files Schedule 13D

   • ASP Isotopes Inc. filed a Schedule 13D on 2026-10-08.
   • LHE LNG Holdings LLC holds 254,015 shares of Endra Life Sciences Inc.
   • The shares represent 15.1% of the company's outstanding stock.

   ASP Isotopes Inc., filed by

2. ROUTINE3ENDRA Life Sciences Inc.NDRAOct 8

   ASPI files Form 3 on 10/08/2026

   • 66,846 common shares held by LHE LNG
   • 511,541 pre-funded warrants
   • 1,156,774 warrants at $6.57

   ASP Isotopes Inc., reporting · LHE LNG Holdings LLC, reporting

3. NOTABLES-4ENDRA Life Sciences Inc.NDRAOct 2

   ENDRA Life Sciences Inc. files S-4 for merger

   • Form S-4 filed on 2026-10-02
   • Merger with Noble Africa and Renergen
   • Noble Africa to receive $50.25M in investment
4. ROUTINE425ENDRA Life Sciences Inc.NDRAOct 1

   Merger communication

5. ROUTINE8-KENDRA Life Sciences Inc.NDRAOct 1

   Current report

6. ROUTINE425ENDRA Life Sciences Inc.NDRASep 25

   Merger communication

7. ROUTINE425ENDRA Life Sciences Inc.NDRASep 14

   Merger communication

8. ROUTINE425ENDRA Life Sciences Inc.NDRASep 9

   Merger communication

   ASP Isotopes Inc., filed by

9. ROUTINE425ENDRA Life Sciences Inc.NDRASep 9

   Merger communication

   ASP Isotopes Inc., filed by

10. ROUTINE425ENDRA Life Sciences Inc.NDRAAug 20

    Merger communication

    ASP Isotopes Inc., filed by

11. ROUTINE425ENDRA Life Sciences Inc.NDRAAug 17

    Merger communication

12. ROUTINE8-KENDRA Life Sciences Inc.NDRAAug 17

    Current report

13. NOTABLE10-QENDRA Life Sciences Inc.NDRAAug 14

    Quarterly report

14. ROUTINE425ENDRA Life Sciences Inc.NDRAAug 6

    Merger communication

    ASP Isotopes Inc., filed by

15. ROUTINE425ENDRA Life Sciences Inc.NDRAAug 5

    Merger communication

    ASP Isotopes Inc., filed by

16. ROUTINE425ENDRA Life Sciences Inc.NDRAAug 4

    Merger communication

    ASP Isotopes Inc., filed by

17. ROUTINE425ENDRA Life Sciences Inc.NDRAJul 22

    Merger communication

    ASP Isotopes Inc., filed by

18. ROUTINE425ENDRA Life Sciences Inc.NDRAJul 22

    Merger communication

    ASP Isotopes Inc., filed by

19. ROUTINE425ENDRA Life Sciences Inc.NDRAJul 17

    Merger communication

    ASP Isotopes Inc., filed by

20. ROUTINE425ENDRA Life Sciences Inc.NDRAJul 17

    Merger communication

21. ROUTINE8-KENDRA Life Sciences Inc.NDRAJul 9

    Current report

22. NOTABLESCHEDULE 13D/AENDRA Life Sciences Inc.NDRAJun 29

    Ownership stake disclosure by Anthony Digiandomenico (amended)

    Anthony Digiandomenico, filed by

23. ROUTINE425ENDRA Life Sciences Inc.NDRAJun 26

    Merger communication

24. ROUTINE8-KENDRA Life Sciences Inc.NDRAJun 26

    Current report

25. ROUTINE144ENDRA Life Sciences Inc.NDRAJun 25

    Anthony Digiandomenico, planned sale of NDRA shares

    Anthony Digiandomenico, reporting

26. ROUTINE425ENDRA Life Sciences Inc.NDRAJun 25

    Merger communication

    ASP Isotopes Inc., filed by

27. ROUTINE425ENDRA Life Sciences Inc.NDRAJun 25

    Merger communication

28. ROUTINE8-KENDRA Life Sciences Inc.NDRAJun 25

    Current report

29. ROUTINE8-KENDRA Life Sciences Inc.NDRAMay 28

    Current report

30. ROUTINERWENDRA Life Sciences Inc.NDRAMay 26

    RW filing

31. ROUTINES-8ENDRA Life Sciences Inc.NDRAMay 15

    Employee stock plan registration

32. NOTABLE10-QENDRA Life Sciences Inc.NDRAMay 15

    Quarterly report

33. ROUTINE8-KENDRA Life Sciences Inc.NDRAApr 21

    Current report

34. NOTABLE10-KENDRA Life Sciences Inc.NDRAMar 31

    Annual report

35. ROUTINE8-KENDRA Life Sciences Inc.NDRAMar 31

    Current report

36. ROUTINE8-KENDRA Life Sciences Inc.NDRAMar 25

    Current report

37. ROUTINE4ENDRA Life Sciences Inc.NDRAMar 4

    2 insider filings

    Alexander Y Tokman, insider filing for NDRA

    Show all 2

    • 4Insider filing for NDRAMar 4
    • 4Insider filing for NDRAMar 4

    Alexander Y Tokman, reporting

38. ROUTINE4ENDRA Life Sciences Inc.NDRAJan 23

    5 insider filings

    Anthony Digiandomenico, insider filing for NDRA

    Show all 5

    • 4Insider filing for NDRAJan 23
    • 4Insider filing for NDRAJan 23
    • 4Insider filing for NDRAJan 23
    • 4Insider filing for NDRAJan 23
    • 4Insider filing for NDRAJan 23

    Anthony Digiandomenico, reporting

39. ROUTINE8-KENDRA Life Sciences Inc.NDRANov 28, 2025

    Current report

40. NOTABLESCHEDULE 13DENDRA Life Sciences Inc.NDRANov 26, 2025

    Ownership stake disclosure by Anthony Digiandomenico

    Anthony Digiandomenico, filed by

41. ROUTINE424B4ENDRA Life Sciences Inc.NDRANov 26, 2025

    Securities offering

42. ROUTINESCHEDULE 13G/AENDRA Life Sciences Inc.NDRANov 14, 2025

    Ownership stake disclosure by L1 Capital Global Opportunities Master Fund, Ltd. (amended)

    L1 Capital Global Opportunities Master Fund, Ltd., filed by

43. ROUTINE8-KENDRA Life Sciences Inc.NDRANov 14, 2025

    Current report

44. NOTABLE10-QENDRA Life Sciences Inc.NDRANov 14, 2025

    Quarterly report

45. ROUTINESCHEDULE 13G/AENDRA Life Sciences Inc.NDRANov 14, 2025

    Ownership stake disclosure by S.H.N. Financial Investments Ltd. (amended)

    S.H.N. Financial Investments Ltd., filed by

Older filings on EDGAR